NICE issues draft guidance on avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy

In DRAFT guidance, NICE does not recommend avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer that has not progressed after platinum-based chemotherapy in adults.

Source:

National Institute for Health and Care Excellence